Log in to search using one of your social media accounts:

 

Early Anticoagulation Strategies Comparable After Afib-Related Stroke (CME/CE)
(MedPage Today) -- NOAC, warfarin show similar safety and efficacy after mild acute ischemic stroke (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 11, 2017 Category: Cardiology Source Type: news

How Moldy Hay And Sick Cows Led To A Lifesaving Drug
The blood thinner warfarin, which prevents blood clots, owes its existence to some cows who got very sick after eating the wrong hay. That and a chemist who spent years trying to figure out why.(Image credit: Avi Ofer) (Source: NPR Health and Science)
Source: NPR Health and Science - August 29, 2017 Category: Consumer Health News Authors: Joe Palca Source Type: news

Apixaban lowers stroke risk in AF patients undergoing cardioversion (EMANATE)
(European Society of Cardiology) Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-na ï ve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

Study: Aspirin Safe for HF Patients (CME/CE)
(MedPage Today) -- Post-hoc WARCEF trial analysis shows no significant risks vs warfarin (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 1, 2017 Category: Cardiology Source Type: news

New Research Supports Safety of Aspirin in Heart Failure
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 1, 2017 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Pharmacy, Pulmonology, Journal, Source Type: news

Study: Aspirin Safe for Heart Failure Patients
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths (Source: WebMD Health)
Source: WebMD Health - July 31, 2017 Category: Consumer Health News Source Type: news

Aspirin Safe for Heart Failure Patients, Study Finds
Large trial comparing it to warfarin finds aspirin not tied to more hospitalizations or deaths Source: HealthDay Related MedlinePlus Pages: Blood Thinners, Heart Failure (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - July 31, 2017 Category: Consumer Health News Source Type: news

How Long Does Coumadin (warfarin) Stay in Your System?
Title: How Long Does Coumadin (warfarin) Stay in Your System?Category: Doctor's& Expert's views on SymptomsCreated: 7/11/2017 12:00:00 AMLast Editorial Review: 7/11/2017 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - July 11, 2017 Category: Cardiology Source Type: news

Dabigatran reduces resource use versus warfarin but not costs
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - June 30, 2017 Category: Drugs & Pharmacology Source Type: news

Registry Data Support NOACs for Single-Risk-Factor AF Registry Data Support NOACs for Single-Risk-Factor AF
Ischemic strokes rates were similar between atrial fibrillation patients treated with novel oral anticoagulants and warfarin, but imbalances in the study groups have raised questions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Jantoven (Warfarin Sodium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 16, 2017 Category: Drugs & Pharmacology Source Type: news

Warfarin, Atrial Fibrillation, and Kidney Function Warfarin, Atrial Fibrillation, and Kidney Function
What do we know about the safety and efficacy of warfarin use among older adults with atrial fibrillation and chronic kidney disease?American Journal of Kidney Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 15, 2017 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Risk of aspirin-related bleeding is higher in the over-75s
Conclusion This valuable cohort study helps to quantify the extent of bleeding risk in people taking aspirin for secondary prevention of cardiovascular disease. Aspirin is well known to carry bleeding risk – particularly in older adults – but this study suggests the risk may be higher than previously thought. The researchers say that for adults under the age of 75, the annual bleeding risk at around 1% is similar to that suggested by previous trials, as is the ratio of bleeds to the number of cardiovascular events. However, this risk increases for older adults, especially for major bleeds of the stomach and upp...
Source: NHS News Feed - June 14, 2017 Category: Consumer Health News Tags: Medication Older people Source Type: news

Rivaroxaban vs. Warfarin in a Patient With AF and LAA Thrombus Rivaroxaban vs. Warfarin in a Patient With AF and LAA Thrombus
This case highlights the possibility of using rivaroxaban as a safe and effective alternative to warfarin in complex cases involving certain thrombophilic conditions.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 2, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Warfarin OK in Expectant Moms with Mechanical Heart Valve
(MedPage Today) -- VKAs generally safer than heparin, according to meta-analysis (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 30, 2017 Category: Geriatrics Source Type: news

Delayed Anticoagulation Raises Dementia Risk in AF Patients Delayed Anticoagulation Raises Dementia Risk in AF Patients
"Unfortunately, the majority of patients who are started on warfarin are started more than 30 days after their initial diagnosis of AF," the lead author said.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 13, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Boston Scientific touts 1-year stroke reduction results in Watchman non-valvular AF trial
Boston Scientific (NYSE:BSX) today released 1-year results from the Ewolution registry study of its Watchman left atrial appendage closure device, touting a high implant success rate and stroke reduction in patients with non-valvular atrial fibrillation patients. Data was presented today at the Heart Rhythm Society’s 39th Annual Scientific Sessions in Chicago. “We are pleased to see that these ‘real-world’ results reinforce the positive outcomes observed in our clinical trial program, despite the registry patients being older and sicker than those enrolled in our previous trials,” rh...
Source: Mass Device - May 12, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials Boston Scientific Source Type: news

Non-major Bleeding in AF Patients on Apixaban vs. Warfarin Non-major Bleeding in AF Patients on Apixaban vs. Warfarin
This study suggests that even non-major bleeding events in patients on oral anticoagulation therapy for AF can have serious outcomes. Is apixaban safer than warfarin in this regard?Heart (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - April 28, 2017 Category: Surgery Tags: Cardiology Journal Article Source Type: news

Study Supports Rivaroxaban as Safe Alternative to Warfarin in VTE (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM A new study adds to evidence that rivaroxaban is a safe and effective alternative to warfarin in patients with unprovoked venous … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 13, 2017 Category: Primary Care Source Type: news

Apr 7 Cardiology News Apr 7 Cardiology News
Cost effects of risk-factor management in AF, apixaban costs vs warfarin, bioresorbable-scaffold woes, exercise as heart-failure therapy, and surgical left atrial appendage closure are discussed.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 7, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Apixaban Cost-effective vs Warfarin in AF: ARISTOTLE Apixaban Cost-effective vs Warfarin in AF: ARISTOTLE
A lifetime on the newer agent was cost-effective within US"reasonable norms" but didn't cut overall costs much by improving outcomes, mostly because apixaban itself is far costlier than warfarin. (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 5, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Use of Warfarin in Veterans With AF After Dementia Diagnosis Use of Warfarin in Veterans With AF After Dementia Diagnosis
Should older adults with AF who have been taking warfarin for stroke prevention continue therapy after being diagnosed with dementia?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 31, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

NOAC'Reasonably' Cost-Effective in Afib (CME/CE)
(MedPage Today) -- Apixaban analysis shows about $54k per QALY vs warfarin (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 29, 2017 Category: Primary Care Source Type: news

Fewer Bleeds on Uninterrupted Dabigatran vs Warfarin in AF Ablation Fewer Bleeds on Uninterrupted Dabigatran vs Warfarin in AF Ablation
"Now we have high-quality data showing that if you perform this procedure on uninterrupted dabigatran, the risk of stroke is extremely low," said a researcher about the randomized RE-CIRCUIT trial.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 28, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Your NEJM Group Today: NEJM Knowledge+ Pediatrics / GI Bleeding with Direct Oral Anticoagulants vs. Warfarin / New Hampshire Family Medicine Opportunity (FREE)
By the Editors Here's today's offering from NEJM Group:NEJM Knowledge+ Pediatrics: We're pleased to announce the launch of NEJM Knowledge+ Pediatrics Board Review. This program … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 28, 2017 Category: Primary Care Source Type: news

Assessing Stroke Risk in Adult Congenital Heart Disease Assessing Stroke Risk in Adult Congenital Heart Disease
Drs Lyle, Ammash, and McLeod discuss risk stratification for stroke in adults with complex congenital heart disease and how to choose between warfarin or the direct oral anticoagulants in the absence of data.Mayo Clinic (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 27, 2017 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Low-dose Apixaban May Be Safe Anti-stroke Option for Dialysis Patients Low-dose Apixaban May Be Safe Anti-stroke Option for Dialysis Patients
Low-dose apixaban achieves blood levels that appear to be safe and might be a “ reasonable alternative ” to warfarin for preventing stroke in patients with atrial fibrillation who are on hemodialysis, new research suggests.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 24, 2017 Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news

Dosing Crucial for Digoxin, Warfarin Safety
(MedPage Today) -- Digoxin unsafe at high levels regardless of heart failure (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 21, 2017 Category: Cardiology Source Type: news

Afib Patients Taking Warfarin May Have Higher Fracture Risk (CME/CE)
(MedPage Today) -- Difference vs dabigatran only in individuals with previous falls or fractures (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 21, 2017 Category: Cardiology Source Type: news

Pradaxa Beats Warfarin After Heart Rhythm Procedure: Study
Patients undergoing surgery to treat an irregular heartbeat are less likely to suffer problematic bleeding when given Pradaxa instead of warfarin, a study finds. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 20, 2017 Category: Consumer Health News Source Type: news

Pradaxa Beats Warfarin After AFib Procedure
Fewer bleeding problems reported among 'ablation' patients who took the newer blood thinner (Source: WebMD Health)
Source: WebMD Health - March 20, 2017 Category: Consumer Health News Source Type: news

Genetically guided warfarin dosing lowers risk of some adverse events
Using genetic testing to help personalize doses of warfarin therapy given to patients undergoing elective orthopedic surgery appears to lower the risk of combined adverse events compared with clinically guided dosing, according to new research. Researchers said these findings could have implications for a broad population of patients starting warfarin therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 20, 2017 Category: Science Source Type: news

Pradaxa Beats Warfarin After Heart Rhythm Procedure
Fewer bleeding problems reported among 'ablation' patients who took the newer blood thinner Source: HealthDay Related MedlinePlus Pages: Atrial Fibrillation, Blood Thinners (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 20, 2017 Category: Consumer Health News Source Type: news

Pradaxa Beats Warfarin After Heart Rhythm Procedure: Study
MONDAY, March 20, 2017 -- Patients undergoing a surgical procedure to treat an irregular heartbeat are less likely to suffer problematic bleeding when given the blood thinner Pradaxa rather than warfarin, a new study finds. The two blood thinners... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 20, 2017 Category: Journals (General) Source Type: news

Pradaxa Beats Warfarin After Heart Rhythm Procedure: Study
Title: Pradaxa Beats Warfarin After Heart Rhythm Procedure: StudyCategory: Health NewsCreated: 3/20/2017 12:00:00 AMLast Editorial Review: 3/20/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 20, 2017 Category: Cardiology Source Type: news

Patients Have High Confidence in Self - Testing INR
Seventy - three percent of patients report being confident in adjusting their own warfarin level (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 17, 2017 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Neurology, Nursing, Oncology, Orthopedics, Pharmacy, Pulmonology, Surgery, Journal, Source Type: news

Are Blood Thinners Overused in Patients With Irregular Heartbeat?
FRIDAY, March 17, 2017 -- Many people living with the heart rhythm disorder known as atrial fibrillation may be taking unneeded blood thinners, a new study suggests. These blood thinners, which include aspirin, Plavix and warfarin, are believed to... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 17, 2017 Category: Journals (General) Source Type: news

Reduced dose of warfarin alternative may help prevent strokes in dialysis patients
In dialysis patients who took 2.5 mg of apixaban twice daily, blood concentrations of the drug were maintained at therapeutic levels. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 16, 2017 Category: Science Source Type: news

Prescription drugs declared "one of the most significant perils to human health" by British medical journal
(Natural News) Prescription drug therapy has been a major contributor to the soaring rates of serious, disabling or fatal injuries, according to a 2011 study published in the British Journal of Medicine. Data from the Institute for Safe Medication Practices showed that anticoagulants dabigatran and warfarin were the most frequently identified medications that were reported to... (Source: NaturalNews.com)
Source: NaturalNews.com - March 15, 2017 Category: Consumer Health News Source Type: news

Estimating the Benefit of Warfarin in Individuals With AF Estimating the Benefit of Warfarin in Individuals With AF
This study focuses on the need to balance the benefits of long-term anticoagulant therapy for AF with an individual's life expectancy and risk of dying from nonthromboembolic causes.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 10, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Dose-Adjusted DOACs: What Efficacy vs Warfarin?
Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start. (Source: ConsultantLive)
Source: ConsultantLive - March 6, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Cerebrovascular Diseases Source Type: news

Genotype-guided warfarin cost effective in Asian MHVR patients
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 28, 2017 Category: Drugs & Pharmacology Source Type: news

NOACs Are Favored Over Warfarin: I'm (Almost) Okay With That NOACs Are Favored Over Warfarin: I'm (Almost) Okay With That
Clinical experience with the new direct-acting oral anticoagulants (DOACs or NOACs) is reassuring, says Dr Mandrola, but independent confirmatory analysis of the data would be even better.theheart.org on Medscape (Source: theHeart.org)
Source: theHeart.org - February 27, 2017 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

Possible Failure of NOACs in Management of Pulmonary Embolism Possible Failure of NOACs in Management of Pulmonary Embolism
Novel oral anticoagulants are fast becoming the drugs of choice when treating pulmonary embolism, but are they always as effective as warfarin?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 24, 2017 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Resuming Warfarin After Brain Bleed Reduces Death Risk (CME/CE)
(MedPage Today) -- Patients with trauma-related bleeds had low second bleed risk (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 20, 2017 Category: Cardiology Source Type: news

Resuming Warfarin After Brain Bleed May Reduce Death Risk (CME/CE)
(MedPage Today) -- Patients with trauma-related bleeds had low second bleed risk (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 20, 2017 Category: Geriatrics Source Type: news

Edoxaban Promising for Valvular Afib?
(MedPage Today) -- NOAC tied to fewer events than warfarin (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - February 17, 2017 Category: Surgery Source Type: news

Net Clinical Benefit of Warfarin in Individuals With AF Net Clinical Benefit of Warfarin in Individuals With AF
This study assessed the net clinical benefit of warfarin, utilizing a widely used and validated clinical prediction score for assessment of ischemic stroke risk in patients with non-valvular AF.Heart (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 17, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

When Atrial Fibrillation and Diabetes Coexist, How Best to Prevent Stroke?
In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention? (Source: ConsultantLive)
Source: ConsultantLive - February 15, 2017 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Cardiovascular Diseases Cerebrovascular Diseases Diabetes Diabetes Type 2 Source Type: news

NOACs Overtake Warfarin in Global Use (CME/CE)
(MedPage Today) -- Agents not there yet in Asia, however (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 13, 2017 Category: Cardiology Source Type: news